Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$1.42
NASDAQLPCN
Open
$1.47
Change
-$0.05 (-3.40%)
Day's Range
$1.41 - $1.51
52-Week Range
$0.49 - $2.43
Volume
734.0K
Market Cap
$125.4M